This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Growing In-Home Consumption Peps Up Soft Drinks Industry Outlook
by Rajani Lohia
Soft drink makers are poised to gain from an accelerating trend of in-home beverage and coffee consumption, despite sluggishness in the away-from-home channel.
Coca-Cola (KO) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Pressures in the away-from-home channels primarily mar Coca-Cola's (KO) second-quarter 2020 top lines. However, earnings top estimates.
CCEP or KO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. KO: Which Stock Is the Better Value Option?
Here's Why Investors Should Buy Monster Beverage (MNST) Stock
by Zacks Equity Research
Monster Beverage (MNST) has been benefiting from strong demand for its energy drinks as well as continuity of operations amid the pandemic.
New Strong Buy Stocks For July 15th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Try Rising P/E Investing Technique With These Top 5 Stocks
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
CCEP or PEP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. PEP: Which Stock Is the Better Value Option?
Coca-Cola (KO) Q4 Earnings & Revenues Beat Estimates, Stock Up
by Zacks Equity Research
Coca-Cola (KO) delivers strong revenue and earnings growth in fourth-quarter 2019. It gains significant value share globally, which along with strong volume and price/mix aids results.
Coca-Cola (KO) Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Coca-Cola's (KO) focus on consumer-centric innovation, solid core brand performance and improved execution in the marketplace bode well.
PepsiCo Strengthens Snacking Unit, Product Launches on Track
by Zacks Equity Research
PepsiCo (PEP) is benefiting from its growing snacks business for a while now. It is also strengthening the Frito-Lay North American with flavorful products.
CCEP vs. PEP: Which Stock Is the Better Value Option?
by Zacks Equity Research
CCEP vs. PEP: Which Stock Is the Better Value Option?
Growth in Hard Seltzer to Aid Boston Beer Despite High Costs
by Zacks Equity Research
Boston Beer's (SAM) investments in the Truly brand are likely to bolster its position in the fast-growing hard seltzer category. However, costs and margin woes are clouding its growth potential.
FEMSA Buys a 40% Socofar Stake, Boosts Drugstore Operations
by Zacks Equity Research
FEMSA's (FMX) acquisition of the remaining 40% stake in Grupo Socofar is likely to bolster its drugstore business in South America and Mexico.
Constellation Brands (STZ) Beats on Q3 Earnings, Ups View
by Zacks Equity Research
Constellation Brands' (STZ) top and bottom lines beat estimates in third-quarter fiscal 2020 on strength in the beer business and improved margins. It raises earnings and cash flow guidance.
Molson Coors to Shut Irwindale Facility, Offers Pabst to Buy
by Zacks Equity Research
Molson Coors (TAP) expects to stop production at its Irwindale, CA-based brewery by September 2020. The move is in sync with its efforts to revitalize and restructure its business.
Weak Volumes & Cost Hurt Molson Coors, Growth Efforts on Track
by Zacks Equity Research
Molson Coors (TAP) is grappling with weakness in volumes and high input cost. However, the company's solid brand portfolio, premiumization efforts and cost-saving initiatives bode well.
FEMSA's (FMX) Unit Acquires AGV, Expands Footprint in Brazil
by Zacks Equity Research
FEMSA's (FMX) subsidiary, Solictica completes the acquisition of AGV. This is an important step for Solistica's Brazilian strategy.
Is Coca-Cola (CCEP) a Potential Stock for Value Investors?
by Zacks Equity Research
Let's see if Coca-Cola (CCEP) stock is a good choice for value-oriented investors right now from multiple angles.
CCEP or PEP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. PEP: Which Stock Is the Better Value Option?
KOF vs. CCEP: Which Stock Is the Better Value Option?
by Zacks Equity Research
KOF vs. CCEP: Which Stock Is the Better Value Option?
Coca-Cola European (CCEP) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Coca-Cola European (CCEP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?
by Zacks Equity Research
The soft drinks space continues to struggle due to higher costs and soft carbonated-drinks sales. Meanwhile, companies' efforts to skew their portfolio toward health drinks and juices should help.
Keurig (KDP) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed fourth-quarter 2018 results, with sales missing estimates and earnings in line. A lower-than-expected earnings view for 2019 hurts investor sentiment.
PepsiCo to Boost Nutrition Portfolio With CytoSport Buyout
by Zacks Equity Research
PepsiCo (PEP) aims to fortify the nutrition brands portfolio with Hormel's CytoSport business, which produces Muscle Milk.
PepsiCo (PEP) Q4 Earnings In Line, Sales Beat Estimates
by Zacks Equity Research
PepsiCo (PEP) reports in-line earnings in fourth-quarter 2018 while sales top estimates. Strong performances in international divisions, along with strength in FLNA and NAB segments, boost results.